The global vaccine adjuvants market is expected to reach USD 769.4 Million by 2021 from USD 467.0 Million in 2016, at a CAGR of 10.5%.
The global market is broadly classified into product type, route of administration, disease type, applications, and application categories.The global market is broadly classified into product type, route of administration, disease type, applications, and application categories.On the basis of product type, the market is segmented into pathogen components, adjuvant emulsions, particulate adjuvants, combination adjuvants, and other adjuvants.Access Free Sample Research Copy : https://www.marketsandmarkets.com/requestsampleNew.asp?id=152603894What Drives the Market?1.
High Prevalence of Infectious and Zoonotic Diseases3.
Increase in Livestock and Instances of Diseases4.
Increasing Focus on Immunization Programs From Various Government Bodies5.
Technological Advancements in Aluminum Hydroxide-Based Adjuvants6.